Cronos Group (TSE:CRON) Shares Up 2.5% – Time to Buy?

Cronos Group Inc. (TSE:CRON)’s share price traded up 2.5% on Tuesday . The stock traded as high as C$3.68 and last traded at C$3.64. 108,808 shares changed hands during mid-day trading, a decline of 38% from the average session volume of 175,697 shares. The stock had previously closed at C$3.55.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group set a C$4.25 price target on Cronos Group and gave the stock a “buy” rating in a report on Tuesday, January 27th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of C$4.25.

Cronos Group Stock Performance

The stock has a market capitalization of C$1.39 billion, a PE ratio of 33.09, a P/E/G ratio of 0.12 and a beta of 1.21. The company has a debt-to-equity ratio of 0.17, a current ratio of 24.24 and a quick ratio of 24.01. The stock has a 50 day moving average of C$3.71 and a two-hundred day moving average of C$3.57.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.